课题基金 / 基金详情

SCGE AAV Tropism Supplement: Evaluation Across Multiple Tissues in Mice

SCGE AAV Tropism Supplement: Evaluation Across Multiple Tissues in Mice
SCGE AAV 趋向性补充:对小鼠多个组织的评估
批准号:
9982649
负责人:
Cathleen M Lutz
金额:
$37.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2020-07-31

项目摘要

项目成果

Cathleen M Lutz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Adeno-Associated Viral (AAV) vectors are a leading technology for the delivery of genome editing machinery. The tropism of some naturally occurring AAV serotypes has been studied in various animal models. However, these surveys are heterogenous in regards to the species studied, tissues examined, cell type resolution, timing and mode of delivery. Additionally, it is unknown how AAV transduction impacts genome editing efficiency. More comprehensive information about the tissue tropism of AAV vectors across several species is needed to accelerate therapeutic development in this area. We propose to assess the tropism and genome editing efficiency of naturally occurring, clinically relevant AAVs in mice. To maximize animal model testing capacity, while centralizing the production of AAV vectors, we have assembled a collaborative team from Baylor, JAX, and UMass. In Aim 1, we will construct a panel of twelve AAV serotypes expressing a fluorescent reporter and luciferase to assess tissue tropism. We will also generate vectors expressing Staphylococcus aureus Cas9 and guide RNAs to evaluate gene editing efficiency. In Aims 2 and 3, we propose to use molecular assays and imaging to evaluate the tissue distribution and expression from each AAV serotype. Ai9 and TLR2 fluorescent reporter allele activation will be used to evaluate the tissue specificity and efficiency AAV-based genome editing for two serotypes. At the end of this 1 year project period, we will have established an atlas of AAV tropism in the mouse, and gained insight into the relationship between AAV delivery and editing efficiency for two serotypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 4: Therapeutic Gene Editing for Rett Syndrome
  • 批准号:
    10668770
  • 项目类别:
  • 资助金额:
    $46.97万
  • 财政年份:
    2023
  • 负责人:
    Cathleen M Lutz
  • 依托单位:
Administrative Core
  • 批准号:
    10668763
  • 项目类别:
  • 资助金额:
    $23.51万
  • 财政年份:
    2023
  • 负责人:
    Cathleen M Lutz
  • 依托单位:
Interrogation of Neurological Pathologies Associated with Mutations in Kif1a
  • 批准号:
    10728701
  • 项目类别:
  • 资助金额:
    $44.2万
  • 财政年份:
    2023
  • 负责人:
    Cathleen M Lutz
  • 依托单位:
Special Mouse Strains Resource
  • 批准号:
    10645429
  • 项目类别:
  • 资助金额:
    $41.01万
  • 财政年份:
    2022
  • 负责人:
    Cathleen M Lutz
  • 依托单位:
海外基金